The PD-L1 assay and the AccuCyte-CyteFinder system processes a single tube of blood to cells for CTC enumeration and PD-L1 biomarker expression analysis, and to plasma for optional cfDNA analysis.
Biocept's Target Selector test enables physicians to identify the potential presence of NTRK fusions used to inform on treatment options.
COVID-19 Compass is based on CDC guidelines, best clinical practices, illness severity, and risk factors such as age, gender, location, potential exposure and pre-existing health conditions.
Cancer diagnostics company Genecast has launched of ADPS BRAF, EGFR, JAK2 mutation test kits with the highest detection sensitivity. Currently available for research use...
Users can sequence up to 48 human genomes, or 384 exomes per run in less than 48 hours.
HDPCR Tick-Borne Pathogen (TBP) Panel is a multiplexPCR test that detects nine of the most common tick-borne pathogens in a single test.
The AmplideX PCR/CE SMN1 kit extends the company’s technology to include the quantification of gene copy number variations.
The TaqPath 1-Step Multiplex Master Mix is designed to detect up to four RNA (or DNA) targets in a single multiplex reaction
ChIP-Seq Spike-in corrects for technical variation that occurs as a result of the multistep ChIP/ChIP-Seq protocols.
This new system features automation from the primary sample tube, greater traceability, and higher throughput.